Vaccines are hard to develop, and can be dangerous. This is a vaccine for a disease where 40% (at current estimate, up from 35% before) have no symptoms, and where only about .4% die. It’s also a widespread disease — this isn’t Ebola where you could vaccinate 50,000 people and bring an outbreak to an end. You’d have to vaccinate a billion or more. When you vaccinate huge numbers of people for a disease that isn’t very dangerous, your vaccine has to be very safe to be better than the disease. That doesn’t go well with a rushed development effort.
UPDATE: Related: Merck CEO says raising COVID-19 vaccine hopes ‘a grave disservice’ – report. “If you’re going to use a vaccine on billions of people, you better know what that vaccine does.”
- Never in history have we had all three issues happening at once…
- Janet Yellen Just Poured Lighter Fluid On Every Small Bank In America
- Here is a detailed list of privacy oriented Search Engines I’ve found that won’t leave information conveniently under the rug
- 2023: A Year When Everything Is Suddenly Breaking Loose All At Once
- Just wow! Elon is losing it bigly.
- Scott Adams: “It’s Going TOO FAR; I’m DANGEROUS Now; I’m Going to HATE You; White Men Are F…ING DONE” (GRAPHIC)
- 186 More Banks “Are At Risk Of Failure”, And That Could Push Us Into The Next Great Depression
- The Great Financial Collapse of 2023. Comparison of Bear Stearns’ collapse in March 2008 and Credit Suisse in March 2023.
- WTF is up with Boot Club & Blackeyes?
- Ellen Brown: The Looming Quadrillion Dollar Derivatives Tsunami